BCL2 and neoplasm: Docetaxel triggers the phosphorylation, and the subsequent inactivation of BCL2 results in apoptosis (36, 37), while quercetin exerts its apoptosis stimulatory impact via p53 activation which, in turn, leads to the upregulation of BAX and downregulation of BCL2 in tumor cells.